Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00010270
Status:
UNKNOWN
Last Update Posted:
2013-12-19
First Post:
2001-02-02
Brief Title:
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic Esophageal Stomach Colon or Rectal Cancer
Sponsor:
University Hospital Freiburg
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pancreatic Cancer |
| Colorectal Cancer |
| Esophageal Cancer |
| Gastric Cancer |
Keywords:
| Name | View |
|---|---|
| stage IV pancreatic cancer | View |
| stage IV colon cancer | View |
| stage IV rectal cancer | View |
| recurrent colon cancer | View |
| recurrent rectal cancer | View |
| adenocarcinoma of the colon | View |
| stage III pancreatic cancer | View |
| stage II pancreatic cancer | View |
| recurrent pancreatic cancer | View |
| adenocarcinoma of the pancreas | View |
| stage IV gastric cancer | View |
| adenocarcinoma of the stomach | View |
| recurrent gastric cancer | View |
| adenocarcinoma of the esophagus | View |
| stage IV esophageal cancer | View |
| stage III esophageal cancer | View |
| recurrent esophageal cancer | View |
| stage II esophageal cancer | View |
| adenocarcinoma of the rectum | View |
| stage III colon cancer | View |
| stage III rectal cancer | View |
| stage III gastric cancer | View |